IP Verse

Methods And Pharmaceutical Compositions For The Treatment Of Age-Related Macular Degeneration (Amd) - EP2909232

The patent EP2909232 was granted to Centre National DE LA Recherche Scientifique Cnrs on Mar 11, 2020. The application was originally filed on Oct 17, 2013 under application number EP13777084A. The patent is currently recorded with a legal status of "Revoked".

EP2909232

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
Application Number
EP13777084A
Filing Date
Oct 17, 2013
Status
Revoked
Apr 4, 2025
Grant Date
Mar 11, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MATHYS & SQUIREDec 11, 2020MACLEANADMISSIBLE

Patent Citations (8) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTEP2383286
INTERNATIONAL-SEARCH-REPORTWO02081513
INTERNATIONAL-SEARCH-REPORTWO2005113586
INTERNATIONAL-SEARCH-REPORTWO2013063383
OPPOSITIONEP2383286
OPPOSITIONWO02081513
OPPOSITIONWO2005113586
OPPOSITIONWO2013063383

Non-Patent Literature (NPL) Citations (19) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- OHKAWA, H.; OHISHI, N.; YAGI, K., "Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction", ANAL BIOCHEM, (1979), vol. 95, doi:doi:10.1016/0003-2697(79)90738-3, pages 351 - 358, XP024827754
DESCRIPTION- LEVEILLARD T; MOHAND-SAID S; LORENTZ 0; HICKS D; FINTZ AC; CLERIN E ET AL., "Identification and characterization of rod-derived cone viability factor", NAT GENET, (2004), vol. 36, doi:doi:10.1038/ng1386, pages 755 - 759, XP002313018
INTERNATIONAL-SEARCH-REPORT- BYRNE LEAH C ET AL, "AAV-mediated Delivery of Rod-derived Cone Viability Factor in a Mouse Model of Retinal Degeneration", ARVO ANNUAL MEETING ABSTRACT SEARCH AND PROGRAM PLANNER, & ANNUAL MEETING OF THE ASSOCIATION-FOR-RESEARCH-IN-VISION-AND-OPHTHALMOLOGY (ARVO); FT LAUDERDALE, FL, USA; MAY 01 -05, 2011, (201105), vol. 2011, page 1395, XP002716687 [A] 1-5 * abstract *
INTERNATIONAL-SEARCH-REPORT- Leah C Byrne ET AL, "AAV-Mediated Delivery of RdCVF and RdCVFL in a Mouse Model of Retinal Degeneration", ARVO 2012 Annual Meeting Abstracts:45 PM -3:30 PM Hall B/C Poster Session Program Program Number: 1907 Poster Board Number: D724, (20120507), URL: http://www.eyes.org.il/Lirot/SendFile.asp?DBID=1&LNGID=2&GID=899, (20131119), XP055089097 [Y] 1-5 * abstract *
INTERNATIONAL-SEARCH-REPORT- T CRONIN ET AL, "The disruption of the rod-derived cone viability gene leads to photoreceptor dysfunction and susceptibility to oxidative stress", CELL DEATH AND DIFFERENTIATION, (20100205), vol. 17, no. 7, doi:10.1038/cdd.2010.2, ISSN 1350-9047, pages 1199 - 1210, XP055045992 [Y] 1-5 * the whole document *
INTERNATIONAL-SEARCH-REPORT- THIERRY LÉVEILLARD ET AL, "Rod-Derived Cone Viability Factor for Treating Blinding Diseases: From Clinic to Redox Signaling", SCIENCE TRANSLATION MEDICINE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, US, (20100407), vol. 2, no. 26, doi:10.1126/SCITRANSLMED.3000866, ISSN 1946-6234, pages 1 - 5, XP009160751 [Y] 1-5 * page 3, column 3, line 1 - line 50 * * page 4, column 1, line 15 - line 20 *
OPPOSITION- BYRNE et al., "AAV-Mediated Delivery of RdCVF andRdCVFL in a Mouse Model of Retinal Degeneration", Invest. Ophthalmol. Vis. Sci. 2012, (20120300), vol. 53, no. 14, page 1907, XP055089097
OPPOSITION- BYRNE et al., "AAV-mediated Delivery of Rodderived Cone Viability Factor in a Mouse Model of Retinal Degeneration", Invest. Ophthalmol. Vis. Sci., (20110000), vol. 52, no. 14, page 1395, XP002716687
OPPOSITION- MATSUURA et al., "Nutritional Supplementation Inhibits the Increase in Serum Malondialdehyde in Patients with Wet Age-Related Macular Degeneration", Oxid Med Cell Longev, (20170124), page 9548767, XP055762621
OPPOSITION- TOTAN et al., "Plasma malondialdehyde and nitric oxide levels in age related macular degeneration", Br J Ophthalmol, (20010000), vol. 85, pages 1426 - 1428, XP055762619
OPPOSITION- ZAJAC-PYTRUS et al., "The Dry Form of Age-Related Macular Degeneration (AMD): The Current Concepts of Pathogenesis and Prospects for Treatment", Adv Clin Exp Med, vol. 24, no. 6, (20150000), pages 1099 - 1104, (20181109), XP055762625
OPPOSITION- YE et al., "Malondialdehyde induces autophagy dysfunction and VEGF secretion in the retinal pigment epithelium in age-related macular degeneration", Free Radical Biology and Medicine, (20160223), vol. 94, pages 121 - 134, XP029518357
OPPOSITION- KERSTEN et al., "Systemic and ocular fluid compounds as potential biomarkers in age-related macular degeneration", Survey of Ophthalmology, (20170515), vol. 63, no. 1, pages 9 - 39, XP085267767
OPPOSITION- CRONIN et al., "The disruption of the rod-derived cone viability gene leads to photoreceptor dysfunction and susceptibility to oxidative stress", Cell Death Differ, (20100205), vol. 17, no. 7, pages 1199 - 1210, XP055045992
OPPOSITION- WEISMANN et al., "Complement factor H binds malondialdehyde epitopes and protects from oxidative stress", Nature, (20111005), vol. 478, no. 7367, pages 76 - 81, XP055044028
OPPOSITION- FRIDLICH et al., "The Thioredoxin-like Protein Rod-derived Cone Viability Factor (RdCVFL) Interacts with TAU and Inhibits Its Phosphorylation in the Retina", Mol Cell Proteomics, (20090311), vol. 8, no. 6, pages 1206 - 1218, XP002742984
OPPOSITION- LEVEILLARD et al., "Rod-Derived Cone Viability Factor for Treating Blinding Diseases: From Clinic to Redox Signaling", Sci Transl Med, (20100407), vol. 2, no. 26, pages 26 - 16, XP009160751
OPPOSITION- BYRNE et al., "Viral-mediated cone and rod photoreceptors in retinal degeneration", J Clin Invest, (20150102), vol. 125, no. 1, pages 105 - 116, XP055230095
OPPOSITION- CHALMEL et al., "Rod-derived Cone Viability Factor-2 is a novel bifunctional-thioredoxin-like protein with therapeutic potential", BMC Molecular Biology, (20070831), vol. 8, page 74, XP021028244

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents